D.E. Shaw & Co’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.36M Sell
621,755
-1,058,874
-63% -$6.34M ﹤0.01% 2490
2025
Q4
$11.7M Buy
1,680,629
+748,012
+80% +$4.92M 0.01% 1617
2025
Q3
$6.01M Buy
932,617
+350,898
+60% +$2.4M ﹤0.01% 2054
2025
Q2
$3.88M Buy
581,719
+33,840
+6% +$174K ﹤0.01% 2223
2025
Q1
$3.55M Buy
547,879
+3,172
+0.6% +$22.8K ﹤0.01% 2160
2024
Q4
$4.39M Buy
544,707
+248,871
+84% +$2.05M ﹤0.01% 2085
2024
Q3
$2.41M Sell
295,836
-117,304
-28% -$773K ﹤0.01% 2571
2024
Q2
$2.88M Sell
413,140
-918,746
-69% -$6.95M ﹤0.01% 2296
2024
Q1
$14.1M Buy
1,331,886
+533,194
+67% +$4.66M 0.01% 1140
2023
Q4
$6.41M Sell
798,692
-1,078,232
-57% -$7.85M 0.01% 1710
2023
Q3
$15.4M Sell
1,876,924
-1,394,683
-43% -$12M 0.02% 1004
2023
Q2
$26.2M Sell
3,271,607
-1,356,903
-29% -$10M 0.03% 733
2023
Q1
$37.5M Sell
4,628,510
-1,581,395
-25% -$12.7M 0.04% 547
2022
Q4
$39M Sell
6,209,905
-2,018,023
-25% -$14.1M 0.04% 539
2022
Q3
$56.7M Buy
8,227,928
+2,636,551
+47% +$18.3M 0.07% 343
2022
Q2
$46.7M Buy
5,591,377
+4,611,318
+471% +$64.5M 0.05% 426
2022
Q1
$22.4M Buy
980,059
+779,205
+388% +$19M 0.02% 955
2021
Q4
$5.55M Buy
+200,854
New +$5.38M ﹤0.01% 2257
2021
Q3
Sell
-160,491
Closed -$4.55M 4958
2021
Q2
$4.71M Buy
160,491
+145,458
+968% +$4.41M ﹤0.01% 2102
2021
Q1
$477K Buy
+15,033
New +$441K ﹤0.01% 3528
2020
Q4
Sell
-95,858
Closed -$1.79M 3915
2020
Q3
$1.49M Buy
95,858
+25,728
+37% +$443K ﹤0.01% 2592
2020
Q2
$1.28M Buy
+70,130
New +$1.24M ﹤0.01% 2756
2019
Q4
Sell
-81,670
Closed -$2.12M 3959
2019
Q3
$1.78M Sell
81,670
-17,461
-18% -$399K ﹤0.01% 2444
2019
Q2
$2.5M Sell
99,131
-231,502
-70% -$5.5M ﹤0.01% 2080
2019
Q1
$8.17M Sell
330,633
-351,113
-52% -$8.39M 0.01% 1240
2018
Q4
$12.6M Sell
681,746
-686,554
-50% -$16.3M 0.02% 948
2018
Q3
$35.1M Buy
1,368,300
+486,409
+55% +$11.1M 0.04% 527
2018
Q2
$20.5M Buy
881,891
+253,873
+40% +$5.25M 0.03% 713
2018
Q1
$10M Sell
628,018
-10,054
-2% -$187K 0.01% 997
2017
Q4
$13.3M Buy
638,072
+76,245
+14% +$1.21M 0.02% 872
2017
Q3
$8.05M Buy
561,827
+198,556
+55% +$3M 0.01% 1069
2017
Q2
$6.29M Buy
363,271
+307,640
+553% +$3.69M 0.01% 1177
2017
Q1
$614K Sell
55,631
-1,605,829
-97% -$22.1M ﹤0.01% 2619
2016
Q4
$24.1M Sell
1,661,460
-496,933
-23% -$9.12M 0.04% 549
2016
Q3
$53M Buy
2,158,393
+232,202
+12% +$6.01M 0.09% 260
2016
Q2
$38.8M Buy
1,926,191
+538,700
+39% +$15.3M 0.07% 330
2016
Q1
$36.5M Buy
1,387,491
+467,125
+51% +$34.5M 0.07% 349
2015
Q4
$93.5M Sell
920,366
-638,851
-41% -$71.8M 0.14% 164
2015
Q3
$278M Sell
1,559,217
-186,295
-11% -$43.4M 0.41% 31
2015
Q2
$388M Sell
1,745,512
-1,343,553
-43% -$298M 0.58% 17
2015
Q1
$614M Buy
3,089,065
+1,373,773
+80% +$244M 0.94% 5
2014
Q4
$245M Buy
1,715,292
+466,574
+37% +$62.8M 0.32% 49
2014
Q3
$164M Sell
1,248,718
-548,870
-31% -$65.4M 0.21% 85
2014
Q2
$227M Sell
1,797,588
-393,427
-18% -$50.2M 0.31% 51
2014
Q1
$289M Buy
2,191,015
+609,949
+39% +$83.4M 0.41% 35
2013
Q4
$186M Buy
1,581,066
+241,985
+18% +$26.5M 0.25% 66
2013
Q3
$140M Sell
1,339,081
-248,459
-16% -$24.2M 0.22% 70
2013
Q2
$137M Buy
+1,587,540
New +$125M 0.26% 56

Other funds holding BHC

D.E. Shaw & Co's BHC Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Bausch Health (BHC) stake by 63% in Q1 2026, selling an estimated $6.34M and leaving 621,755 shares worth $3.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2490.

D.E. Shaw & Co first reported a position in BHC in Q2 2013 and has held it in 48 quarters since. The position peaked at $614M in Q1 2015. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • D.E. Shaw & Co held 621,755 shares of Bausch Health worth $3.36M as of Q1 2026.
  • D.E. Shaw & Co sold 1,058,874 Bausch Health shares in Q1 2026, an estimated $6.34M.
  • Bausch Health made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2490 holding.
  • D.E. Shaw & Co first reported a position in Bausch Health in Q2 2013 and has held it in 48 quarters since.
  • D.E. Shaw & Co's Bausch Health position peaked at $614M in Q1 2015.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.